BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $37,360 | +9.9% | 601,133 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $34,000 | -12.8% | 601,133 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $39,000 | -84.5% | 601,133 | -43.3% | 0.00% | -80.0% |
Q1 2022 | $251,000 | -62.4% | 1,060,104 | -0.0% | 0.01% | -58.3% |
Q4 2021 | $668,000 | – | 1,060,504 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kingstown Capital | 300,000 | $18,000 | 0.06% |
Radcliffe Capital Management, L.P. | 202,950 | $2,014,000 | 0.05% |
RAMIUS ADVISORS LLC | 567,986 | $34,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 63,832 | $633,000 | 0.02% |
MARSHALL WACE, LLP | 575,000 | $5,709,000 | 0.01% |
Telemetry Investments, L.L.C. | 153,694 | $9,000 | 0.01% |
Q Global Advisors, LLC | 300,000 | $15,000 | 0.01% |
LMR Partners LLP | 50,000 | $496,000 | 0.01% |
Segantii Capital Management Ltd | 25,000 | $248,000 | 0.01% |
Corbin Capital Partners, L.P. | 464,062 | $28,000 | 0.01% |